[1]
|
Globocan Observatory W (2019) Cancer Today—World. International Agency for Research on Cancer, 876, 2018-2019.
|
[2]
|
Thomassen, I., van Gestel, Y.R., van Ramshorst, B., et al. (2014) Peritoneal Carcinomatosis of Gastric Origin: A Population-Based Study on Incidence, Survival and Risk Factors. International Journal of Cancer, 134, 622-628.
https://doi.org/10.1002/ijc.28373
|
[3]
|
Ikoma, N., Blum, M., Chiang, Y.J., et al. (2016) Yield of Staging Laparos-copy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer. Annals of Surgical Oncology, 23, 4332-4337.
https://doi.org/10.1245/s10434-016-5409-7
|
[4]
|
Allen, C.J., Newhook, T., Vreeland, T.J., et al. (2019) Yield of Peritoneal Cytology in Staging Patients with Gastric and Gastroesophageal Cancer. Journal of Surgical Oncology, 120, 1350-1357. https://doi.org/10.1002/jso.25729
|
[5]
|
Sugarbaker, P.H. (2016) Cytoreductive Surgery and Hyper-thermic Intraperitoneal Chemotherapy in the Management of Gastrointestinal Cancers with Peritoneal Metastases: Pro-gress toward a New Standard of Care. Cancer Treatment Reviews, 48, 42-49. https://doi.org/10.1016/j.ctrv.2016.06.007
|
[6]
|
Yonemura, Y., Canbay, E., Li, Y., et al. (2016) A Comprehensive Treatment for Peritoneal Metastases from Gastric Cancer with Curative Intent. European Journal of Surgical Oncology, 42, 1123-1131.
https://doi.org/10.1016/j.ejso.2016.03.016
|
[7]
|
Seshadri, R.A. and Glehen, O. (2016) Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric cancer. World Journal of Gastroenterology, 22, 1114-1130. https://doi.org/10.3748/wjg.v22.i3.1114
|
[8]
|
Desiderio, J., Chao, J., Melstrom, L., Warner, S., Tozzi, F., Fong, Y., Parisi, A. and Woo, Y. (2017) The 30-Year Experience—A Meta-Analysis of Randomised and High-Quality Non-Randomised Studies of Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer. European Journal of Cancer, 79, 1-14.
https://doi.org/10.1016/j.ejca.2017.03.030
|
[9]
|
Ji, Z.H., Peng, K.W., Yu, Y., Li, X.B., Yonemura, Y., Liu, Y., Sugarbaker, P.H. and Li, Y. (2017) Current Status and Future Prospects of Clinical Trials on CRS+HIPEC for Gastric Cancer Peritoneal Metastases. International Journal of Hyperthermia, 33, 562-570. https://doi.org/10.1080/02656736.2017.1283065
|
[10]
|
Dahdaleh, F.S. and Turaga, K.K. (2018) Evolving Treatment Strategies and Outcomes in Advanced Gastric Cancer with Peritoneal Metastasis. Surgical Oncology Clinics of North America, 27, 519-537.
https://doi.org/10.1016/j.soc.2018.02.006
|
[11]
|
Yonemura, Y., Sako, S., Wakama, S., et al. (2019) History of Peri-toneal Surface Malignancy Treatment in Japan. Indian Journal of Surgical Oncology, 10, 3-11. https://doi.org/10.1007/s13193-019-00893-x
|
[12]
|
Jayne, D. (2007) Molecular Biology of Peritoneal Carcinomato-sis. In: Ceelen, W.P., Ed., Cancer Treatment and Research, Springer, Berlin, 21-31. https://doi.org/10.1007/978-0-387-48993-3_2
|
[13]
|
Ji, Z.H., Peng, K.W. and Li, Y. (2016) Intraperitoneal Free Cancer Cells in Gastric Cancer: Pathology of Peritoneal Carcinomatosis and Rationale for Intraperitoneal Chemothera-py/Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. Translational Gastroenterology and Hepatology, 1, 69. https://doi.org/10.21037/tgh.2016.08.03
|
[14]
|
Ji, Z.H., Zhang, Y. and Li, Y. (2021) Intra-Operative Hyperthermic Intraperitoneal Chemotherapy for Prevention and Treatment of Peritoneal Metastases from Gastric Cancer: A Narrative Review. Journal of Gastrointestinal Oncology, 12, S70-S78. https://doi.org/10.21037/jgo-20-262
|
[15]
|
Merboth, F., Garcia, S., Renesse, V.J., Distler, M., Welsch, T., Weitz, J. and Stange, D.E. (2022) Comparative Analysis of Postopera-tive Complications after Cytoreductive Surgery and HIPEC in Gastric Cancer. Oncology Research and Treatment, 45, 45-53. https://doi.org/10.1159/000520330
|
[16]
|
Fugazzola, P., Coccolini, F., Montori, G., Ceresoli, M., Baggi, P., Costanzo, A., Tomasoni, M., Gregis, F., Nozza, S. and Ansaloni, L. (2017) Overall and Disease-Free Survival in Pa-tients Treated with CRS+HIPEC with Cisplatin and Paclitaxel for Gastric Cancer with Peritoneal Carcinomatosis. Journal of Gastrointestinal Oncology, 8, 572-582.
https://doi.org/10.21037/jgo.2017.03.11
|
[17]
|
Rihuete Caro, C., Manzanedo, I., Pereira, F., Carrion-Alvarez, L., Serrano, Á. and Pérez-Viejo, E. (2018) Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemother-apy (HIPEC) in Patients with Gastric Cancer and Peritoneal Carcinomatosis. European Journal of Surgical Oncology, 44, 1805-1810.
https://doi.org/10.1016/j.ejso.2018.06.036
|
[18]
|
Koemans, W.J., van der Kaaij, R.T., Wassenaar, E.C.E., Boerma, D., Boot, H., Sikorska, K., Los, M., Grootscholten, C., Hartemink, K.J., Veenhof, A.A.F.A., Kodach, L., Snaebjornsson, P. and van Sandick, J.W. (2021) Tumor Characteristics and Clinical Outcome of Peritoneal Metastasis of Gastric Origin Treated with a Hyperthermic Intraperitoneal Chemotherapy Procedure in the PERISCOPE I Trial. Journal of Surgical Oncology, 123, 904-910.
https://doi.org/10.1002/jso.26366
|
[19]
|
Zhu, L., Xu, Z., Wu, Y., Liu, P., Qian, J., Yu, S., Xia, B., Lai, J., Ma, S. and Wu, Z. (2020) Prophylactic Chemotherapeutic Hyperthermic Intraperitoneal Perfusion Reduces Peritoneal Metastasis in Gastric Cancer: A Retrospective Clinical Study. BMC Cancer, 20, Article No. 827. https://doi.org/10.1186/s12885-020-07339-6
|
[20]
|
Boerner, T., Graichen, A., Jeiter, T., Zemann, F., Renner, P., März, L., Soeder, Y., Schlitt, H.J., Piso, P. and Dahlke, M.H. (2016) CRS-HIPEC Prolongs Survival but Is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer. Annals of Surgical Oncology, 23, 3972-3977. https://doi.org/10.1245/s10434-016-5306-0
|
[21]
|
Bălescu, I., Godoroja, D., Gongu, M., Tomulescu, V. and Copăescu, C. (2017) Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer—Technique and Early Outcomes of Our First Cases. Chirurgia (Bucur), 112, 714-725. https://doi.org/10.21614/chirurgia.112.6.714
|
[22]
|
Badgwell, B., Blum, M., Das, P., Estrella, J., Wang, X., Ho, L., Fournier, K., Royal, R., Mansfield, P. and Ajani, J. (2017) Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma. Annals of Surgical Oncology, 24, 3338-3344.
https://doi.org/10.1245/s10434-017-6047-4
|
[23]
|
Newhook, T.E., Agnes, A., Blum, M., Estrella, J.S., Das, P., Ho, L., Ajani, J.A., Minsky, B.D., Mansfield, P. and Badgwell, B.D. (2019) Laparoscopic Hyperthermic Intraperitoneal Chemotherapy Is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy. Annals of Surgical Oncology, 26, 1394-1400.
https://doi.org/10.1245/s10434-018-07140-7
|
[24]
|
Sadeghi, B., Arvieux, C., Glehen, O., Beaujard, A.C., Rivoire, M., Baulieux, J., et al. (2000) Peritoneal Carcinomatosis from Non-Gynecologic Malignancies: Results of the EVOCAPE 1 Multicentric Prospective Study. Cancer, 88, 358-363. https://doi.org/10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O
|
[25]
|
Yang, X.J., Huang, C.Q., Suo, T., Mei, L.J., Yang, G.L., Cheng, F.L., et al. (2011) Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Re-sults of a Phase III Randomized Clinical Trial. Annals of Surgical Oncology, 18, 1575-1581.
https://doi.org/10.1245/s10434-011-1631-5
|